September 13, 2013 07:23 ET

PZ Cormay and Voxel to Present at WDM Capital 1st Global Life Sciences Conference in Warsaw, Poland on September 17, 2013

WARSAW, POLAND--(Marketwired - Sep 13, 2013) - PZ Cormay and Voxel announced that it will present at WDM Capital 1st Global Life Sciences Conference in Warsaw, to be held at the Warsaw Stock Exchange in Warsaw, Poland on September 16-17, 2013.

PZ Cormay Group is the leader in in vitro diagnostics (IVD) in Central and Eastern Europe. Its products are present in over 150 countries. The main business areas are biochemistry, haematology and immunology with a portfolio of innovative analysers and highest quality assays. The Group sells its products as PZ Cormay (Poland), Orphee (Switzerland), Audit Diagnostics (Ireland) and Diesse (Italy). The Group's innovative projects are supported by an experienced international R&D team. PZ Cormay Group is currently commercialising a revolutionary diagnostic assay technology which will enable performance of the full spectrum of tests from one drop of blood collected from the fingertip without the use of a syringe or a sample tube. The tests will be performed within several minutes and their accuracy will significantly exceed current standards. The devices will be small in size and the cost of their purchase and service will be very competitive. The world premiere of the new generation analyser dedicated for doctors' offices was made during AACC fairs in the USA (July/August 2013). For more information please visit

Voxel Group is the market leader in Poland in diagnostic imaging by offering a comprehensive range of services and products associated with the use of the latest technological advances in medicine. The company provides services in the field of diagnostic imaging (own diagnostic centers, incl. PET-CT), teleradiology outsourcing and provides IT systems for hospitals and diagnostic centers and deals with the implementation of projects fitting the diagnostic laboratory. Voxel Group produces also radiopharmaceuticals and introduces new technologies on the market, e.g. robotic pharmacy and Gamma Knife for stereotactic radiosurgery used to treat brain disorder such as brain tumor and vascular malformations, without the need for open surgery. The company brings together a unique team of professionals with extensive clinical experience and recognized scientific achievements. For more information please visit

A live webcast of both presentations can be accessed through the following link:

WDM, a prominent small cap investment bank in Central and Eastern Europe, is organizing the conference in partnership with Filipex Enterprises, the Warsaw Stock Exchange and Deloitte. For more information, visit

About WDM

WDM is Central and Eastern Europe's leading small cap investment bank. It has been listed on the Warsaw Stock Exchange since 2007. Over the past 6 years, WDM has taken over 50 companies public on the Warsaw Stock Exchange. It has raised over $150,000,000 in private equity, venture capital and public financing for its clients. WDM's investment management subsidiary, WDM Capital, manages a growing portfolio of some of the region's most promising micro caps. WDM's United States subsidiary, WDM Capital USA, provides access to CEE financing and investment opportunities for North American clients and North American financing and market access for CEE clients. For more information visit:

Contact Information